Literature DB >> 26862747

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3.

Alexa C Robitaille1, Mélissa K Mariani2, Audray Fortin3, Nathalie Grandvaux4.   

Abstract

The IRF3 transcription factor is critical for the first line of defense against pathogens mainly through interferon β and antiviral gene expression. A detailed analysis of IRF3 activation is essential to understand how pathogens induce or evade the innate antiviral response. Distinct activated forms of IRF3 can be distinguished based on their phosphorylation and monomer vs dimer status. In vivo discrimination between the different activated species of IRF3 can be achieved through the separation of IRF3 phosphorylated forms based on their mobility shifts on SDS-PAGE. Additionally, the levels of IRF3 monomer and dimer can be monitored using non-denaturing electrophoresis. Here, we detail a procedure to reach the highest resolution to gain the most information regarding IRF3 activation status. This is achieved through the combination of a high resolution SDS-PAGE and a native-PAGE coupled to immunoblots using multiple total and phosphospecific antibodies. This experimental strategy constitutes an affordable and sensitive approach to acquire all the necessary information for a complete analysis of the phosphorylation-mediated activation of IRF3.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26862747      PMCID: PMC4781702          DOI: 10.3791/53723

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  30 in total

1.  Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation.

Authors:  Bin Y Qin; Cheng Liu; Suvana S Lam; Hema Srinath; Rachel Delston; John J Correia; Rik Derynck; Kai Lin
Journal:  Nat Struct Biol       Date:  2003-10-12

2.  Ser386 phosphorylation of transcription factor IRF-3 induces dimerization and association with CBP/p300 without overall conformational change.

Authors:  Kiyohiro Takahasi; Masataka Horiuchi; Kiyonaga Fujii; Shingo Nakamura; Nobuo N Noda; Mitsutoshi Yoneyama; Takashi Fujita; Fuyuhiko Inagaki
Journal:  Genes Cells       Date:  2010-07-06       Impact factor: 1.891

3.  Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation.

Authors:  Benjamin R tenOever; Marc J Servant; Nathalie Grandvaux; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes.

Authors:  Nathalie Grandvaux; Marc J Servant; Benjamin tenOever; Ganes C Sen; Siddarth Balachandran; Glen N Barber; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5.

Authors:  Nathalie Grandvaux; Xiaochun Guan; Fabrice Yoboua; Nicolas Zucchini; Karin Fink; Priscilla Doyon; Lydie Martin; Marc J Servant; Stéfany Chartier
Journal:  J Innate Immun       Date:  2014-04-30       Impact factor: 7.349

6.  Differential modification of interferon regulatory factor 3 following virus particle entry.

Authors:  Ryan S Noyce; Susan E Collins; Karen L Mossman
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

7.  Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation.

Authors:  Claire E McCoy; Susan Carpenter; Eva M Pålsson-McDermott; Linden J Gearing; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2008-03-20       Impact factor: 5.157

8.  Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association.

Authors:  Jean-François Clément; Annie Bibeau-Poirier; Simon-Pierre Gravel; Nathalie Grandvaux; Eric Bonneil; Pierre Thibault; Sylvain Meloche; Marc J Servant
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

9.  Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation.

Authors:  Mitsuaki Mori; Mitsutoshi Yoneyama; Takashi Ito; Kiyohiro Takahashi; Fuyuhiko Inagaki; Takashi Fujita
Journal:  J Biol Chem       Date:  2003-12-31       Impact factor: 5.157

10.  HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).

Authors:  Stéphanie Olière; Eduardo Hernandez; Agnès Lézin; Meztli Arguello; Renée Douville; Thi Lien-Anh Nguyen; Stéphane Olindo; Gérard Panelatti; Mirdad Kazanji; Peter Wilkinson; Rafick-Pierre Sékaly; Raymond Césaire; John Hiscott
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

View more
  11 in total

1.  RNA sensor LGP2 inhibits TRAF ubiquitin ligase to negatively regulate innate immune signaling.

Authors:  Jean-Patrick Parisien; Jessica J Lenoir; Roli Mandhana; Kenny R Rodriguez; Kenin Qian; Annie M Bruns; Curt M Horvath
Journal:  EMBO Rep       Date:  2018-04-16       Impact factor: 8.807

2.  ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.

Authors:  Rodney Cheng-En Hsieh; Sunil Krishnan; Ren-Chin Wu; Akash R Boda; Arthur Liu; Michelle Winkler; Wen-Hao Hsu; Steven Hsesheng Lin; Mien-Chie Hung; Li-Chuan Chan; Krithikaa Rajkumar Bhanu; Anupallavi Srinivasamani; Ricardo Alexandre De Azevedo; Yung-Chih Chou; Ronald A DePinho; Matthew Gubin; Eduardo Vilar; Chao Hsien Chen; Ravaen Slay; Priyamvada Jayaprakash; Shweta Mahendra Hegde; Genevieve Hartley; Spencer T Lea; Rishika Prasad; Brittany Morrow; Coline Agnes Couillault; Madeline Steiner; Chun-Chieh Wang; Bhanu Prasad Venkatesulu; Cullen Taniguchi; Yon Son Betty Kim; Junjie Chen; Nils-Petter Rudqvist; Michael A Curran
Journal:  Sci Immunol       Date:  2022-06-10

3.  Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer.

Authors:  Rajendra Kumar; Janet Mendonca; Olutosin Owoyemi; Kavya Boyapati; Naiju Thomas; Suthicha Kanacharoen; Max Coffey; Deven Topiwala; Carolina Gomes; Busra Ozbek; Tracy Jones; Marc Rosen; Liang Dong; Sadie Wiens; W Nathaniel Brennen; John T Isaacs; Angelo M De Marzo; Mark C Markowski; Emmanuel S Antonarakis; David Z Qian; Kenneth J Pienta; Drew M Pardoll; Michael A Carducci; Samuel R Denmeade; Sushant K Kachhap
Journal:  Cancer Res       Date:  2021-10-13       Impact factor: 13.312

4.  Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.

Authors:  Philippa Hillyer; Rachel Shepard; Megan Uehling; Mina Krenz; Faruk Sheikh; Kalyn R Thayer; Lei Huang; Lihan Yan; Debasis Panda; Cindy Luongo; Ursula J Buchholz; Peter L Collins; Raymond P Donnelly; Ronald L Rabin
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

5.  DUSP1 regulates apoptosis and cell migration, but not the JIP1-protected cytokine response, during Respiratory Syncytial Virus and Sendai Virus infection.

Authors:  Alexa C Robitaille; Elise Caron; Nicolas Zucchini; Espérance Mukawera; Damien Adam; Mélissa K Mariani; Anaïs Gélinas; Audray Fortin; Emmanuelle Brochiero; Nathalie Grandvaux
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

6.  Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes.

Authors:  Carlene Petes; Mélissa K Mariani; Yawen Yang; Nathalie Grandvaux; Katrina Gee
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

7.  THO Complex Subunit 7 Homolog Negatively Regulates Cellular Antiviral Response against RNA Viruses by Targeting TBK1.

Authors:  Tian-Sheng He; Tao Xie; Jing Li; Ya-Xian Yang; Changsheng Li; Weiying Wang; Lingzhen Cao; Hua Rao; Cynthia Ju; Liang-Guo Xu
Journal:  Viruses       Date:  2019-02-15       Impact factor: 5.048

8.  The Combination of IFN β and TNF Induces an Antiviral and Immunoregulatory Program via Non-Canonical Pathways Involving STAT2 and IRF9.

Authors:  Mélissa K Mariani; Pouria Dasmeh; Audray Fortin; Elise Caron; Mario Kalamujic; Alexander N Harrison; Diana I Hotea; Dacquin M Kasumba; Sandra L Cervantes-Ortiz; Espérance Mukawera; Adrian W R Serohijos; Nathalie Grandvaux
Journal:  Cells       Date:  2019-08-17       Impact factor: 6.600

9.  Degradation of WTAP blocks antiviral responses by reducing the m6 A levels of IRF3 and IFNAR1 mRNA.

Authors:  Yong Ge; Tao Ling; Yao Wang; Xin Jia; Xiongmei Xie; Rong Chen; Shangwu Chen; Shaochun Yuan; Anlong Xu
Journal:  EMBO Rep       Date:  2021-09-01       Impact factor: 8.807

10.  Virus Infection Triggers MAVS Polymers of Distinct Molecular Weight.

Authors:  Natalia Zamorano Cuervo; Quentin Osseman; Nathalie Grandvaux
Journal:  Viruses       Date:  2018-01-30       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.